CHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building ...

Novo Nordisk has submitted a supplemental application to the FDA for Rybelsus 14 mg to lower cardiovascular risk in adults ...

In this video, Girish N Nadkarni, MD, a professor of medicine at the Icahn School of Medicine at Mount Sinai, discusses recent advancements in chronic kidney disease care.

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in ...

Currently, there are six FDA approved weight loss medications. They include three GLP-1 receptor agonists -- liraglutide ...

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist the treatment. The answer to this antimicrobial resistance, which the ...

Popular brands like Prilosec, Nexium, and Prevacid are often taken daily to reduce stomach acid and help manage conditions ...

Tremfya is also approved to treat patients with plaque psoriasis, active psoriatic arthritis and ulcerative colitis and is ...

Pharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 millionCash and cash ...

At the request of the FDA a type B meeting package will be provided by the ... (6,7), type 2 diabetes mellitus (8), chronic kidney disease (9), and premature mortality (6,10,11). About the XRx-026 ...